A Randomized, Controlled Study to Evaluate the Sensitizing Potential of FMX-101 in Healthy Volunteers Using a Repeat Insult Patch Test Design
Clinical trial NCT04052711 · COMPLETED
Trial details
- NCT number
- NCT04052711
- Sponsor
- Vyne Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-09-08
- Primary completion
- 2016-11-19
- Enrollment
- 233
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.